Mutations in the IDH1 and IDH2 genes strongly correlate with the development of glioma, acute myeloid leukemia, chondrosarcoma, intrahepatic cholangiocarcinoma, and angioimmunoblastic carcinomas of T-cell lymphomas [52]. This evidence concerns the gene IDH2 and central nervous system cancer.